Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rina Zilkha-Falb

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Stem Cell Reports|May 16, 2020
The Median Eminence, A New Oligodendrogenic Niche in the Adult Mouse BrainRina Zilkha-Falb, Nathali Kaushansky, Avraham Ben-Nun
International Journal of Molecular Sciences|November 27, 2025
Beta Interferon 1a and Laquinimod Differentially Affect Coagulation-Related Gene Expression in Multiple Sclerosis Patients: Implications for Clinical Efficacy and Side EffectsMichael Gurevich, Rina Zilkha-Falb, Joab Chapman, et al.
Neuroscience|September 23, 2017
Prickle1 as positive regulator of oligodendrocyte differentiationRina Zilkha-Falb, Michael Gurevich, Erez Hanael, et al.
Autoimmunity Reviews|August 18, 2009
The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosisNathali Kaushansky, Miriam Eisenstein, Rina Zilkha-Falb, et al.
Journal of Neuroinflammation|January 10, 2016
Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like diseaseRina Zilkha-Falb, Nathali Kaushansky, Naoto Kawakami, et al.
Plos One|February 7, 2023
Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity studyGil Harari, Michael Gurevich, Mark Dolev, et al.
Journal of Neuroinflammation|October 21, 2020
RAM-589.555 favors neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected miceRina Zilkha-Falb, Tatyana Rachutin-Zalogin, Lakota Cleaver, et al.
Journal of Neuroimmunology|September 4, 2013
Polymerase I pathway inhibitor ameliorates experimental autoimmune encephalomyelitisAnat Achiron, Roi Mashiach, Rina Zilkha-Falb, et al.
BMC Neurology|November 22, 2015
Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosisMichael Gurevich, Gadi Miron, Rina Zilkha Falb, et al.
Journal of Neurovirology|May 13, 2016
Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patientsAnat Achiron, Gadi Miron, Rina Zilkha-Falb, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Stem Cell Reports|May 16, 2020
The Median Eminence, A New Oligodendrogenic Niche in the Adult Mouse BrainRina Zilkha-Falb, Nathali Kaushansky, Avraham Ben-Nun
International Journal of Molecular Sciences|November 27, 2025
Beta Interferon 1a and Laquinimod Differentially Affect Coagulation-Related Gene Expression in Multiple Sclerosis Patients: Implications for Clinical Efficacy and Side EffectsMichael Gurevich, Rina Zilkha-Falb, Joab Chapman, et al.
Neuroscience|September 23, 2017
Prickle1 as positive regulator of oligodendrocyte differentiationRina Zilkha-Falb, Michael Gurevich, Erez Hanael, et al.
Autoimmunity Reviews|August 18, 2009
The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosisNathali Kaushansky, Miriam Eisenstein, Rina Zilkha-Falb, et al.
Journal of Neuroinflammation|January 10, 2016
Post-CNS-inflammation expression of CXCL12 promotes the endogenous myelin/neuronal repair capacity following spontaneous recovery from multiple sclerosis-like diseaseRina Zilkha-Falb, Nathali Kaushansky, Naoto Kawakami, et al.
Plos One|February 7, 2023
Faster progression to multiple sclerosis disability is linked to neuronal pathways associated with neurodegeneration: An ethnicity studyGil Harari, Michael Gurevich, Mark Dolev, et al.
Journal of Neuroinflammation|October 21, 2020
RAM-589.555 favors neuroprotective and anti-inflammatory profile of CNS-resident glial cells in acute relapse EAE affected miceRina Zilkha-Falb, Tatyana Rachutin-Zalogin, Lakota Cleaver, et al.
Journal of Neuroimmunology|September 4, 2013
Polymerase I pathway inhibitor ameliorates experimental autoimmune encephalomyelitisAnat Achiron, Roi Mashiach, Rina Zilkha-Falb, et al.
BMC Neurology|November 22, 2015
Transcriptional response to interferon beta-1a treatment in patients with secondary progressive multiple sclerosisMichael Gurevich, Gadi Miron, Rina Zilkha Falb, et al.
Journal of Neurovirology|May 13, 2016
Host cell virus entry mechanisms enhance anti-JCV-antibody switch in natalizumab-treated multiple sclerosis patientsAnat Achiron, Gadi Miron, Rina Zilkha-Falb, et al.
Pageof 2